The US has launched Operation Trialblazer, an effort to strengthen clinical trials. The initiative appears to be part of a broader push to restore american leadership in clinical research and biomedical innovation, potentially in response to international competition. Details of the plan are emerging, with some outlets suggesting it aims to accelerate and modernize clinical development, though its impact on existing delays is uncertain.